世界の細胞および遺伝子治療薬製造サービス市場は、2022年に49億ドルと推定され、2023年までに57億ドル、2028年までに118億ドルに拡大、2023年から2028年の予測期間中15.7％のCAGRが見込まれます。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Chapter- 2: Summary and Highlights
Market Overview
Chapter- 3: Market Overview and Technology Background
Overview
Manufacturing
Supply Chain
Regulatory Landscape
Outsourcing of Manufacturing
Chapter- 4: Market Dynamics
Factors Affecting the Market
Market Drivers
Market Restraints
Chapter- 5: Emerging Technologies
Introduction
Emerging Technologies
Emerging Manufacturing Models
Chapter- 6: Market Breakdown by Type
Overview
Cell Therapy
Gene Therapy
Cell Therapy Types
Cell and Gene Therapy Types Based on Vector Type
Chapter- 7: Market Breakdown by Application
Overview
Clinical Manufacturing
Commercial Scale Manufacturing
Chapter- 8: Market Breakdown by Disease
Overview
Cancer
Rare Diseases
Other Diseases
Chapter- 9: Market Breakdown by End User
Overview
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Others
Chapter- 10: Market Breakdown by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter- 11: Sustainability: An ESG Perspective
Overview
Case Studies: Examples of Successful ESG Implementation
Conclusion
Chapter- 12: M&A, Funding Outlook and Competitive Landscape
Investments Outlook
Mergers and Acquisitions
Competitive Analysis
Chapter- 13: Company Profiles
CATALENT INC.
CELL AND GENE THERAPY CATAPULT
CHARLES RIVER LABORATORIES
FUJIFILM DIOSYNTH BIOTECHNOLOGIES
LONZA GROUP AG
MERCK KGAA
MILTENYI BIOTEC
NIKON CELL INNOVATION CO. LTD.
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC
WUXI ADVANCED THERAPIES
